Neurovascular Devices Market Size, Share, Growth Analysis, By Disease Pathology(Cerebral Aneurysm, Arteriovenous Malformation And Fistulas, Ischemic Stroke, Carotid Artery Stenosis), By End Use(Hospitals and Surgical Centers, Ambulatory Care Centers, Research Laboratories and Academic Institutes), By Region - Industry Forecast 2024-2031

Global Neurovascular Devices Market size was valued at USD 2.90 Billion in 2022 and is poised to grow from USD 3.15 Billion in 2023 to USD 6.04 Billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031). 

Neurovascular device manufacturers should focus on making their products more affordable to increase their sales potential. Entering developing and under-developed countries should also be a priority for neurovascular device companies going forward. The incorporation of advanced technologies to improve the capabilities of neurovascular devices will also be a key trend for new as well as established neurovascular devices market players. Investing in research will be a strategy that no neurovascular devices company should skip going forward.   'Acandis GmbH (Germany)  ', 'Asahi Intecc Co. Ltd. (Japan)  ', 'Imperative Care Inc. (United States)  ', 'Integer Holdings Corporation (United States)  ', 'Johnson & Johnson (United States)  ', 'Medtronic plc (Ireland)  ', 'MicroPort Scientific Corporation (China)  ', 'Penumbra Inc. (United States)  ', 'Perflow Medical Ltd. (Israel)  ', 'Rapid Medical (Canada)  ', 'Stryker Corporation (United States)  ', 'Terumo Corporation (Japan)  ', 'Balt (Switzerland)  ', 'WL Gore & Associates (United States)  ', 'Penumbra, Inc. (United States) (duplicate)  ', 'Silk Road Medical (United States)  ', 'Siemens Healthineers AG (Germany)  ', 'Le Maire Vascular (France)  ', 'Boston Scientific Corporation (United States)  ', 'InspireMD, Inc. (Israel) '

Poor lifestyle choices and growing adoption of unhealthy habits have significantly increased the number of people suffering from neurovascular diseases. This surge in incidence of neurovascular issues such as strokes and cerebral aneurysms around the world is a key factor promoting neurovascular device demand. 

Development of Minimally Invasive Devices: Preference of minimally invasive procedures is increasing rapidly around the world owing to faster recovery and ease of treatment. Neurovascular device manufacturers should focus on the development of devices that can perform minimally invasive procedures to ensure robust sales growth in the long run.  

North America secures the top spot when it comes to global neurovascular devices demand. The presence of a developed healthcare infrastructure, high healthcare spending potential, and easy availability of advanced neurovascular devices are forecasted to be key factors contributing to the dominance of this region. The United States is slated to be the most opportune market in this region owing to high prevalence of ischemic strokes. Canada is also estimated to provide lucrative opportunities for neurovascular devices companies in this region. Favorable reimbursement and high investments medical research are also expected to help North America maintain its dominance.